MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LIETMAN, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LIETMAN, P. S.

Molecular Pharmacology, Vol 7, 122-128, Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics

Mitochondrial Protein Synthesis: Inhibition by Emetine Hydrochloride

PAUL S. LIETMAN 1

1 Department of Pediatrics and Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Emetine hydrochloride has previously been described as an inhibitor of ribosomal protein synthesis in eukaryotic cells but not in bacteria [A. P. Grollman, Proc. Nat. Acad. Sci. U. S. A. 56, 1867 (1966)]. I wish to report that this ipecac alkaloid inhibits protein synthesis in mitochondrial systems derived from mouse liver. Structural relatives of emetine, such as isoemetine hydrobromide and O-methylpsychotrine oxylate, which are relatively ineffective as inhibitors of ribosomal protein synthesis, also inhibit mitochondrial protein synthesis but at concentrations that are about an order of magnitude greater than those required for inhibition by emetine hydrochloride. Anisomycin, which also inhibits ribosomal protein synthesis in eukaryotic cells but not in bacteria, fails to inhibit mitochondrial protein synthesis. These findings reveal new structural and conformational subtleties with respect to the susceptibility of various protein-synthesizing systems to ipecac alkaloids and their conformational analogues, the glutarimide antibiotics.

Note:
ACKNOWLEDGMENT Excellent technical assistance was provided by Mrs. Elizabeth Moen.

Submitted on July 30, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics